News

Australian drug industry seeks to improve its image

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39551.656875.C2 (Published 17 April 2008) Cite this as: BMJ 2008;336:850
  1. Bob Burton
  1. 1Hobart

    Australia’s leading drug industry lobby group, Medicines Australia, is canvassing options on how to counter what it describes as “challenges” to its “credibility and trust.” The move comes after new rules were introduced making it mandatory for drug companies to publicly disclose details of their involvement in meetings and conferences for doctors (BMJ 2008;336:742; doi: 10.1136/bmj.39535.488299.DB).

    The lobby group’s annual one day “members only” conference included presentations from an ethicist on “ethical conduct,” a public relations adviser on “shaping a new image,” and a market researcher on “moral responsibility and corporate reputation.”

    In the conference programme the group’s chief executive, Ian Chalmers, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe